Peer-reviewed veterinary case report
Mitral valve repair outcomes in dogs with heart valve disease
By Lee, Jeong-Min et al.·Published in Journal of veterinary internal medicine·2025·Korea Animal Medical Center, South Korea·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Retrospective Evaluation of Transcatheter Edge-To-Edge Mitral Valve Repair in Dogs With Myxomatous Mitral Valve Disease.
- Species:
- dog
Plain-English summary
A group of 20 dogs with myxomatous mitral valve disease (MMVD), a heart condition, underwent a new minimally invasive procedure called transcatheter edge-to-edge repair (TEER) to improve their heart function. While 13 of the dogs survived the procedure, 7 unfortunately passed away within 9 days due to various complications, including heart-related issues and tracheal collapse. However, the dogs that did survive showed significant improvements in heart size and function three months after the treatment. This suggests that TEER could be a promising option for dogs suffering from MMVD, but more research is needed to ensure its safety and effectiveness.
People also search for: dog heart disease treatment · myxomatous mitral valve disease in dogs · TEER procedure for dogs · dog heart surgery recovery · signs of heart problems in dogs
Abstract
BACKGROUND: Transcatheter edge-to-edge repair (TEER) is an emerging minimally invasive mitral valve repair treatment for dogs with myxomatous mitral valve disease (MMVD), but reports on its outcomes are limited. OBJECTIVE: Describe the clinical characteristics and complications in dogs with MMVD undergoing TEER. ANIMALS: Twenty client-owned dogs with MMVD stages B2, C, and D. METHODS: Retrospective case series. Cases were identified by review of hospital medical records between September 2023 and September 2024. RESULTS: Twenty dogs underwent TEER; of these, 13 (65%) survived. Seven dogs died within 9 days because of mitral leaflet tear or single-leaflet device attachment (4/7 dogs, 57.1%), tracheal collapse (1/7 dogs, 14.3%), presumed post-procedure neurologic deficit with a history of hydrocephalus (1/7 dogs, 14.3%), and presumed cardiogenic shock (1/7 dogs, 14.3%). Significant reductions in vertebral heart score (11.6 [9.6-13.1] vs. 11.0 [8.3-11.9] vertebrae; p < 0.01), vertebral left atrial size (2.90 [2.1-3.6] vs. 2.60 [2.0-3.3] vertebrae; p < 0.01), left atrium-to-aortic root ratio (2.09 [1.5-2.5] vs. 1.69 [1.3-2.2]; p < 0.05), left ventricular end-diastolic diameter normalized for body weight (2.1 [1.5-2.3] vs. 1.76 [1.4-2.2]; p < 0.05), regurgitant fraction (77.83 [73.2-83.0] vs. 55.38 [20.5-73.6] %; p < 0.05), and regurgitant volume (3.96 [2.1-6.2] vs. 1.25 [0.4-3.5] ml/kg; p < 0.05) were observed 3 months after TEER. CONCLUSIONS AND CLINICAL IMPORTANCE: Transcatheter edge-to-edge repair resulted in a significant reduction in left atrium and ventricle size and should be further investigated as a potential treatment option for dogs with MMVD.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40459365/